FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 138 filers reported holding FLEXION THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $296,000 | +11.3% | 21,630 | 0.0% | 0.01% | +25.0% |
| Q2 2019 | $266,000 | -1.5% | 21,630 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $270,000 | +80.0% | 21,630 | +63.1% | 0.01% | +33.3% |
| Q4 2018 | $150,000 | -39.5% | 13,260 | 0.0% | 0.01% | -25.0% |
| Q3 2018 | $248,000 | -27.7% | 13,260 | 0.0% | 0.01% | -33.3% |
| Q2 2018 | $343,000 | +53.8% | 13,260 | +33.5% | 0.01% | +33.3% |
| Q1 2018 | $223,000 | -92.9% | 9,930 | -93.0% | 0.01% | -96.5% |
| Q2 2015 | $3,119,000 | -27.0% | 142,483 | -24.9% | 0.26% | -33.2% |
| Q1 2015 | $4,270,000 | -32.9% | 189,624 | -39.8% | 0.38% | -44.7% |
| Q4 2014 | $6,363,000 | -25.2% | 315,144 | -32.4% | 0.69% | -29.5% |
| Q3 2014 | $8,508,000 | +25.2% | 465,933 | -7.6% | 0.98% | +19.3% |
| Q2 2014 | $6,795,000 | -16.2% | 504,083 | +2.2% | 0.82% | -15.0% |
| Q1 2014 | $8,113,000 | – | 493,183 | – | 0.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,842,578 | $40,001,000 | 7.32% |
| MILLER VALUE PARTNERS, LLC | 5,274,439 | $54,907,000 | 1.97% |
| Mesirow Financial Investment Management, Inc. | 32,371 | $337,000 | 1.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,068,580 | $11,124,000 | 1.25% |
| Clearline Capital LP | 399,159 | $4,155,000 | 1.09% |
| CLOUGH CAPITAL PARTNERS L P | 1,246,150 | $12,972,000 | 0.93% |
| Novo Holdings A/S | 1,403,370 | $14,609,000 | 0.72% |
| SNOW CAPITAL MANAGEMENT LP | 303,265 | $3,157,000 | 0.63% |
| AMERICAN FINANCIAL GROUP INC | 317,700 | $3,308,000 | 0.46% |
| Granahan Investment Management | 1,257,690 | $13,093,000 | 0.44% |